Who owns Eton Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ETON from SEC Form 13F filings across 214 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 214 institutions disclosed 22.1M shares of Eton Pharmaceuticals, Inc. worth $1.14B — about 77.1% of shares outstanding; the largest disclosed holder is EcoR1 Capital, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
214
13F holders
$1.14B
value, 2026 filers
77.1%
of shares outstanding (22.1M sh)
76
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ETON's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | EcoR1 Capital, LLC | 2.5M | $127.2M | 5.6% | 8.6% | +13.8% |
| 2 | Opaleye Management Inc. | 2.4M | $125.6M | 14.2% | 8.5% | -14.7% |
| 3 | BlackRock, Inc. | 2.1M | $107.9M | 0.0% | 7.3% | +10.6% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $62.0M | 0.0% | 4.2% | +23.2% |
| 5 | Nantahala Capital Management, LLC | 875,507 | $45.1M | 1.4% | 3.1% | -25.5% |
| 6 | FMR LLC | 823,587 | $42.4M | 0.0% | 2.9% | +38657.0% |
| 7 | STATE STREET CORP | 775,543 | $39.9M | 0.0% | 2.7% | +10.5% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 764,398 | $39.4M | 0.0% | 2.7% | +17.2% |
| 9 | MORGAN STANLEY | 513,174 | $26.4M | 0.0% | 1.8% | -33.2% |
| 10 | OBERWEIS ASSET MANAGEMENT INC/ | 500,403 | $25.8M | 0.6% | 1.7% | -0.2% |
| 11 | National Philanthropic Trust | 492,112 | $25.3M | 0.4% | 1.7% | 0.0% |
| 12 | MARSHALL WACE, LLP | 457,432 | $23.6M | 0.0% | 1.6% | +83.6% |
| 13 | Westside Investment Management, Inc. | 401,385 | $20.7M | 2.6% | 1.4% | -6.9% |
| 14 | Woodline Partners LP | 309,071 | $15.9M | 0.0% | 1.1% | -0.6% |
| 15 | Soleus Capital Management, L.P.NEW | 308,101 | $15.9M | 0.6% | 1.1% | new |
| 16 | Pillsbury Lake Capital LLC | 288,266 | $14.8M | 5.7% | 1% | -25.5% |
| 17 | Nuveen, LLC | 271,213 | $14.0M | 0.0% | 0.9% | -27.8% |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 270,012 | $13.9M | 0.0% | 0.9% | +38.8% |
| 19 | NORTHERN TRUST CORP | 264,683 | $13.6M | 0.0% | 0.9% | +3.5% |
| 20 | GOLDMAN SACHS GROUP INC | 262,778 | $13.5M | 0.0% | 0.9% | +98.2% |
| 21 | Janus Henderson Group Ltd.NEW | 252,705 | $13.0M | 0.0% | 0.9% | new |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 249,210 | $12.8M | 0.0% | 0.9% | +223.5% |
| 23 | Rockefeller Capital Management L.P.NEW | 223,699 | $11.5M | 0.0% | 0.8% | new |
| 24 | DIMENSIONAL FUND ADVISORS LP | 212,889 | $11.0M | 0.0% | 0.7% | +401.1% |
| 25 | THOMPSON SIEGEL & WALMSLEY LLC | 211,447 | $10.9M | 0.2% | 0.7% | -28.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.